Kids v Cancer is proud to announce that Congress passed the Creating Hope Reauthorization Act as part of the Stimulus Package. This win will create a four year extension to the pediatric voucher program, incentivizing drug development for kids with life threatening illnesses. more→
CREATING HOPE ACT & PEDIATRIC PRIORITY REVIEW VOUCHERS NEWS
New Cancer Drug, Three More for Rare Pediatric Diseases Approved, and a Voucher Sells for $95 Million
A new drug for neuroblastoma and three more drugs for rare pediatric diseases approved during Thanksgiving week, earning the vouchers under the Creating Hope Act. more→
Congress Provides Short Term Reauthorization for the Pediatric Voucher Program
The House of Representatives passed the Creating Hope Reauthorization Act to extend the rare pediatric disease voucher program for four years. more→
Reauthorize the Creating Hope Act to help kids with rare diseases (The Washington Post)
The inspirational story of 10-year-old Autumn Schierling’s fight with neurofibromatosis and the successful development of selumetinib for her condition offer a timely example of how a law can help children with rare diseases. more→
Creating Hope: In Support of the Creating Hope Reauthorization Act, Making the Rare Pediatric Disease Priority Review Voucher Program Permanent (Testimony by Nancy Goodman)
Testimony before the Health Subcommittee of the U.S. House of Representatives Energy and
Commerce Committee, July 29, 2020. Nancy Goodman, Founder of Kids v Cancer more→
Kids v Cancer urges Congress to permanently reauthorize pediatric voucher program (The Cancer Letter)
The Creating Hope Reauthorization Act (S. 4010) would permanently reauthorize the pediatric voucher program. more→
The Creating Hope Reauthorization Act Introduced in the Senate!
Today the Creating Hope Reauthorization Act has been introduced in the Senate. The pediatric priority review voucher program encourages the development of new drugs for seriously ill children, including children with cancer. This is a must-pass bill. more→
Creating Hope Reauthorization Act of 2019 Introduced in Congress
Introduced in the House of Representatives on 9/20/2019, Creating Hope Reauthorization Act (H. R. 4439) seeks to make the Rare Pediatric Disease Priority Review Voucher program permanent. more→
Pediatric Cancer Legislative Yearbook 2020
Download the Legislative Yearbook 2020 and learn about legislative agenda of childhood cancer community. Updated September 2019.
Creating Hope Act Permanent Reauthorization of 2019
The Creating Hope Act passed in 2012, was reauthorized several times, and sunsets September 30, 2020. The Creating Hope Act pediatric priority more→
Another Voucher Sold for $95 Million
Priority review vouchers, created under the Creating Hope Act of 2012 and awarded by FDA since 2014, have brought to market 19 new rare pediatric disease medicines. more→
FDA Updates Draft Guidance on Pediatric Priority Review Vouchers
FDA expects 51 rare pediatric disease designation requests and 20 priority review voucher requests annually. more→
Priority Review Voucher Sold for $105 million
The PRV program, established under the Creating Hope Act in 2012, encourages development of new drug and biological products for rare pediatric diseases. more→
Climb the Hill Youth Advocacy Day — Why Do I Do It?
Watch our youth advocates and cancer survivors describe their meetings with congressional staffers and advocating for kids with cancer. more→
Everything you need to know about FDA’s Priority Review Vouchers (RAPS Regulatory Explainer)
What are the Priority Review Vouchers and how do they benefit the society? more→